|
|
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
10.6 |
pA2 |
- |
5 |
|
| ⤷ |
pA2
10.6
[5]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
9.3 – 9.9 |
pA2 |
- |
2,6,9-10 |
|
| ⤷ |
pA2
9.3 – 9.9
[2,6,9-10]
|
|
β1-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
9.3 – 9.9 |
pA2 |
- |
6,9-10 |
|
| ⤷ |
pA2
9.3 – 9.9
[6,9-10]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
9.4 – 10.6 |
pKi |
- |
3-5,12-13,15 |
|
| ⤷ |
pKi
9.4 – 10.6
[3-5,12-13,15]
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
9.4 – 10.6 |
pKi |
- |
3-5,8,12-13,15 |
|
| ⤷ |
pKi
9.4 – 10.6
[3-5,8,12-13,15]
|
|
β2-adrenoceptor
|
|
|
Rn |
Antagonist |
Partial agonist |
9.7 |
pKi |
- |
5 |
|
| ⤷ |
pKi
9.7
[5]
|
|
β1-adrenoceptor
|
|
|
Rn |
Antagonist |
Partial agonist |
9.4 |
pKi |
- |
5 |
|
| ⤷ |
pKi
9.4
[5]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.7 – 9.8 |
pKi |
- |
3-5,8-9,11-13 |
|
| ⤷ |
pKi
8.7 – 9.8
[3-5,8-9,11-13]
|
|
β1-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
8.7 – 9.8 |
pKi |
- |
3-5,8-9,12-13,15 |
|
| ⤷ |
pKi
8.7 – 9.8
[3-5,8-9,12-13,15]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.3 – 9.4 |
pKi |
- |
3,5,12 |
|
| ⤷ |
pKi
8.3 – 9.4
[3,5,12]
|
|
β3-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
8.3 – 9.4 |
pKi |
- |
3,5,12 |
|
| ⤷ |
pKi
8.3 – 9.4
[3,5,12]
|
|
α1A-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.4 |
pKi |
- |
14 |
|
| ⤷ |
pKi
8.4
[14]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
9.1 – 9.4 |
pEC50 |
- |
4,7 |
|
| ⤷ |
pEC50
9.1 – 9.4
[4,7]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.6 – 9.2 |
pEC50 |
- |
4,6,8 |
|
| ⤷ |
pEC50
7.6 – 9.2
[4,6,8]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
6.1 – 7.2 |
pEC50 |
- |
1 |
|
| ⤷ |
pEC50
6.1 – 7.2
[1]
|
|